Indeed, animal models of chronic viral infection and cancer have demonstrated that PD1+LAG3 combination blockade is more effective than either alone [107,108], and of the 33 ongoing registered clinical trials of LAG3-blockade, all but two are testing LAG3+PD1 combination blockade. Here, LAG3 is linked to cancer.